Keywords
Blood Glucose
Body Mass Index
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To analyze thyroid function in patients with glycemic alterations who underwent tests in a Clinical Laboratory, located in Goiânia (GO). Methods: This is a cross-sectional and retrospective study using data from the test results of 623 individuals, of both sexes, aged 18 to 90 years, who underwent tests at the clinical laboratory between February and March 2023. The inclusion criteria were: performance of TSH, Free T4, and fasting glucose tests, with the latter necessarily altered. The data were tabulated using Microsoft Excel, subjected to descriptive statistics, and the Student's t-test, with a significance level of 5%. Results: The sample consisted of 408 (65.5%) women and 215 (34.5%) men, and the predominant age group was 50 to 69 years. In the TSH test, 11.08% of the population presented altered values, while 88.92% presented normal values. Regarding Free T4, 4.97% showed alterations, while 95.03% were normal. A higher prevalence of altered TSH was observed in women, and similarity between sexes regarding altered BMI, with a predominance of overweight, followed by grade 1 obesity. Conclusion: It is concluded that monitoring thyroid function is necessary in patients with glycemic alterations, especially in women.
References
AHMAD E, et al. Type 2 diabetes. The Lancet, 2022; 400(10365):1803-1820.
AMERICAN DIABETES ASSOCIATION. Classification and diagnosis of diabetes: Standards of medical care in diabetes—2021. Diabetes Care, 2021; 44(Supl. 1): S15-S33.
BARDUGO, A, et al. Adolescent Thyroid Disorders and Risk for Type 2 Diabetes in Young Adulthood. The Journal of Clinical Endocrinology & Metabolism, 2021; 106(9): e3426-e3435.
BENSENOR IM. Thyroid disorders in Brazil: the contribution of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil). Brazilian Journal of Medical and Biological Research, 2019; 52(2): e8417.
BIONDI B, et al. Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders. Endocrine Reviews, 2019; 40(3): e789-824.
CHÁVEZ-GUEVARA IA, et al. The role of sex in the relationship between fasting adipokines levels, maximal fat oxidation during exercise, and insulin resistance in young adults with excess adiposity. Biochemical Pharmacology, 2023; 216: e115757.
ELMENSHAWI IM, et al. Prevalence of Thyroid Dysfunction in Diabetic Patients. Journal of Diabetes, Metabolic Disorders & Control, 2017; 4(2): e55-60.
EOM YS, et al. Links between Thyroid Disorders and Glucose Homeostasis. Diabetes & Metabolism Journal, 2022 ;46(2): 239–56.
GOLDMAN L. Goldman Cecil Medicina. 25 ed. Rio de Janeiro: Elsevier, 2018; 1530p.
GREEN A, et al. Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults. Diabetologia, 2021; 64(12): e2741-2750.
GREGORY GA, et al. Global incidence, prevalence, and Mortality of Type 1 Diabetes in 2021 with Projection to 2040: a Modelling Study. The Lancet Diabetes & Endocrinology, 2022; 10(10): e741-760.
GUARINO S, et al. Sensitivity to thyroid hormones in children developing acute kidney injury at the onset of type 1 diabetes mellitus. BMC Medicine, 2025; 23(1): e123.
HILAWE EH, et al. Differences by sex in the prevalence of diabetes mellitus, impaired fasting glycaemia and impaired glucose tolerance in sub-Saharan Africa: a systematic review and meta-analysis. Bulletin of the World Health Organization, 2013; 91(9): e671-682D.
JIFFRI EH. Relationship between Lipid Profile Blood and Thyroid Hormones in Patient with Type 2 Diabetes Mellitus. Advances in Obesity, Weight Management & Control, 2017; 6(6): e178-182.
KHASSAWNEH AH, et al. Prevalence and Predictors of Thyroid Dysfunction Among Type 2 Diabetic Patients: A Case–Control Study. International Journal of General Medicine, 2020; 13: e803-816.
KOCEŁAK P, et al. Prevalence and risk factors of untreated thyroid dysfunctions in the older Caucasian adults: Results of PolSenior 2 survey. PLoS ONE, 2022; 17(8): e0272045.
LEFEVRE ML. Screening for Thyroid Dysfunction: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine, 2015; 162(9): e641.
LIU B, et al. Sensitivity to Thyroid Hormones and Risk of Prediabetes: A Cross-Sectional Study. Frontiers in Endocrinology, 2021;12: 657114.
MANCINI MC, et al. Diretrizes brasileiras de obesidade 2016. Associação Brasileira para o Estudo da Obesidade e da Síndrome Metabólica (ABESO), 2016; 4.
ONG KL, et al. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. The Lancet,2023; 402: e10397.
PERSKY V, et al. Sex Hormones and Diabetes in 45- to 74-year-old Men and Postmenopausal Women: The Hispanic Community Health Study. The Journal of Clinical Endocrinology & Metabolism, 2023; 108(7).
PRETZ D, et al. Hyperleptinemia as a contributing factor for the impairment of glucose intolerance in obesity. The FASEB Journal, 2020; 35(2): e21216.
RODACKI M, et al. Diagnóstico de diabetes mellitus: Diretriz Oficial da Sociedade Brasileira de Diabetes – 2024. Sociedade Brasileira de Diabetes, 2024, ISBN: 978-65-272-0704-7.
TORRE F, et al. Effects of oral contraceptives on thyroid function and vice versa. Journal of Endocrinological Investigation, 2020; 43(9): e11818.
WIERSINGA WM, et al. Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis. The Lancet Diabetes & Endocrinology, 2023;11(4).
XIE J, et al. Research progress on estrogen and estrogen receptors in the occurrence and progression of autoimmune thyroid diseases. Autoimmunity Reviews, 2025; 24(6): e103803.
ZHANG X, et al. Trends in Prevalence of Thyroid Dysfunction and its Associations With Mortality Among US Participants, 1988-2012. The Journal of Clinical Endocrinology and Metabolism, 2024; 109(2): e65766.